Table 2

Baseline echocardiographic measurements according to the median baseline RVol/LAV ratio

All patients (n = 567)RVol/LAV ≥ 0.67 (n = 284)RVol/LAV < 0.67 (n = 283)P-value
EROA by PISA (cm²)0.40 ± 0.130.44 ± 0.130.36 ± 0.11<0.0001
RVol by PISA (cm²)58.2 ± 18.367.3 ± 17.849.1 ± 13.9<0.0001
Vena contracta (cm)0.6 ± 0.10.6 ± 0.10.6 ± 0.10.23
Regurgitant fraction (%)36.2 ± 14.236.7 ± 14.335.8 ± 14.20.62
LVEF (%)31.2 ± 9.331.6 ± 9.330.8 ± 9.40.31
LVEF ≤ 40%441 (82.3)226 (83.4)215 (81.1)0.49
LV GLS (%)−11.95 ± 3.44−12.26 ± 3.44−11.62 ± 3.430.03
LVEDVi (mL/m²)101.8 ± 35.098.5 ± 34.0105.1 ± 35.80.03
LVESVi (mL/m²)71.5 ± 29.768.5 ± 28.074.5 ± 31.00.02
LV SVi (mL/m²)50.5 ± 16.951.2 ± 17.049.8 ± 16.80.32
Left atrial volume (mL)91.2 ± 38.671.2 ± 20.9111.2 ± 41.8<0.0001
LAVi (mL/m2)48.3 ± 20.538.4 ± 11.258.2 ± 22.9<0.0001
LA strain (%)12.7 ± 4.614.1 ± 4.811.3 ± 3.9<0.0001
SPAP (mmHg)44.1 ± 13.444.2 ± 14.144.0 ± 12.70.90
Tricuspid regurgitation ≥ 2+90 (16.2)53 (19.1)37 (13.3)0.06
RV fractional change area (%)32.0 ± 9.032.8 ± 8.631.2 ± 9.40.08
RV free wall strain (%)−17.8 ± 5.0−18.2 ± 4.9−17.4 ± 5.00.12
All patients (n = 567)RVol/LAV ≥ 0.67 (n = 284)RVol/LAV < 0.67 (n = 283)P-value
EROA by PISA (cm²)0.40 ± 0.130.44 ± 0.130.36 ± 0.11<0.0001
RVol by PISA (cm²)58.2 ± 18.367.3 ± 17.849.1 ± 13.9<0.0001
Vena contracta (cm)0.6 ± 0.10.6 ± 0.10.6 ± 0.10.23
Regurgitant fraction (%)36.2 ± 14.236.7 ± 14.335.8 ± 14.20.62
LVEF (%)31.2 ± 9.331.6 ± 9.330.8 ± 9.40.31
LVEF ≤ 40%441 (82.3)226 (83.4)215 (81.1)0.49
LV GLS (%)−11.95 ± 3.44−12.26 ± 3.44−11.62 ± 3.430.03
LVEDVi (mL/m²)101.8 ± 35.098.5 ± 34.0105.1 ± 35.80.03
LVESVi (mL/m²)71.5 ± 29.768.5 ± 28.074.5 ± 31.00.02
LV SVi (mL/m²)50.5 ± 16.951.2 ± 17.049.8 ± 16.80.32
Left atrial volume (mL)91.2 ± 38.671.2 ± 20.9111.2 ± 41.8<0.0001
LAVi (mL/m2)48.3 ± 20.538.4 ± 11.258.2 ± 22.9<0.0001
LA strain (%)12.7 ± 4.614.1 ± 4.811.3 ± 3.9<0.0001
SPAP (mmHg)44.1 ± 13.444.2 ± 14.144.0 ± 12.70.90
Tricuspid regurgitation ≥ 2+90 (16.2)53 (19.1)37 (13.3)0.06
RV fractional change area (%)32.0 ± 9.032.8 ± 8.631.2 ± 9.40.08
RV free wall strain (%)−17.8 ± 5.0−18.2 ± 4.9−17.4 ± 5.00.12

Data are reported as mean ± SD, or n (%).

EROA, effective regurgitant orifice area; GLS, global longitudinal strain; LA, left atrium; LAV, left atrial volume; LV SVi, left ventricular stoke volume index; LVEDVi, left ventricular end-diastolic volume index; LVESVi, left ventricular end-systolic volume index; LVEF, left ventricular ejection fraction; LVMi, left ventricular mass index; MR, mitral regurgitation; PISA, proximal isovelocity surface area; RAVi, right atrial volume index; RV, right ventricle; RVol, regurgitant volume; SPAP, systolic pulmonary artery pressure.

Table 2

Baseline echocardiographic measurements according to the median baseline RVol/LAV ratio

All patients (n = 567)RVol/LAV ≥ 0.67 (n = 284)RVol/LAV < 0.67 (n = 283)P-value
EROA by PISA (cm²)0.40 ± 0.130.44 ± 0.130.36 ± 0.11<0.0001
RVol by PISA (cm²)58.2 ± 18.367.3 ± 17.849.1 ± 13.9<0.0001
Vena contracta (cm)0.6 ± 0.10.6 ± 0.10.6 ± 0.10.23
Regurgitant fraction (%)36.2 ± 14.236.7 ± 14.335.8 ± 14.20.62
LVEF (%)31.2 ± 9.331.6 ± 9.330.8 ± 9.40.31
LVEF ≤ 40%441 (82.3)226 (83.4)215 (81.1)0.49
LV GLS (%)−11.95 ± 3.44−12.26 ± 3.44−11.62 ± 3.430.03
LVEDVi (mL/m²)101.8 ± 35.098.5 ± 34.0105.1 ± 35.80.03
LVESVi (mL/m²)71.5 ± 29.768.5 ± 28.074.5 ± 31.00.02
LV SVi (mL/m²)50.5 ± 16.951.2 ± 17.049.8 ± 16.80.32
Left atrial volume (mL)91.2 ± 38.671.2 ± 20.9111.2 ± 41.8<0.0001
LAVi (mL/m2)48.3 ± 20.538.4 ± 11.258.2 ± 22.9<0.0001
LA strain (%)12.7 ± 4.614.1 ± 4.811.3 ± 3.9<0.0001
SPAP (mmHg)44.1 ± 13.444.2 ± 14.144.0 ± 12.70.90
Tricuspid regurgitation ≥ 2+90 (16.2)53 (19.1)37 (13.3)0.06
RV fractional change area (%)32.0 ± 9.032.8 ± 8.631.2 ± 9.40.08
RV free wall strain (%)−17.8 ± 5.0−18.2 ± 4.9−17.4 ± 5.00.12
All patients (n = 567)RVol/LAV ≥ 0.67 (n = 284)RVol/LAV < 0.67 (n = 283)P-value
EROA by PISA (cm²)0.40 ± 0.130.44 ± 0.130.36 ± 0.11<0.0001
RVol by PISA (cm²)58.2 ± 18.367.3 ± 17.849.1 ± 13.9<0.0001
Vena contracta (cm)0.6 ± 0.10.6 ± 0.10.6 ± 0.10.23
Regurgitant fraction (%)36.2 ± 14.236.7 ± 14.335.8 ± 14.20.62
LVEF (%)31.2 ± 9.331.6 ± 9.330.8 ± 9.40.31
LVEF ≤ 40%441 (82.3)226 (83.4)215 (81.1)0.49
LV GLS (%)−11.95 ± 3.44−12.26 ± 3.44−11.62 ± 3.430.03
LVEDVi (mL/m²)101.8 ± 35.098.5 ± 34.0105.1 ± 35.80.03
LVESVi (mL/m²)71.5 ± 29.768.5 ± 28.074.5 ± 31.00.02
LV SVi (mL/m²)50.5 ± 16.951.2 ± 17.049.8 ± 16.80.32
Left atrial volume (mL)91.2 ± 38.671.2 ± 20.9111.2 ± 41.8<0.0001
LAVi (mL/m2)48.3 ± 20.538.4 ± 11.258.2 ± 22.9<0.0001
LA strain (%)12.7 ± 4.614.1 ± 4.811.3 ± 3.9<0.0001
SPAP (mmHg)44.1 ± 13.444.2 ± 14.144.0 ± 12.70.90
Tricuspid regurgitation ≥ 2+90 (16.2)53 (19.1)37 (13.3)0.06
RV fractional change area (%)32.0 ± 9.032.8 ± 8.631.2 ± 9.40.08
RV free wall strain (%)−17.8 ± 5.0−18.2 ± 4.9−17.4 ± 5.00.12

Data are reported as mean ± SD, or n (%).

EROA, effective regurgitant orifice area; GLS, global longitudinal strain; LA, left atrium; LAV, left atrial volume; LV SVi, left ventricular stoke volume index; LVEDVi, left ventricular end-diastolic volume index; LVESVi, left ventricular end-systolic volume index; LVEF, left ventricular ejection fraction; LVMi, left ventricular mass index; MR, mitral regurgitation; PISA, proximal isovelocity surface area; RAVi, right atrial volume index; RV, right ventricle; RVol, regurgitant volume; SPAP, systolic pulmonary artery pressure.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close